Neurotransmitters: emerging targets in cancer

SH Jiang, LP Hu, X Wang, J Li, ZG Zhang - Oncogene, 2020 - nature.com
Neurotransmitters are conventionally viewed as nerve-secreted substances that mediate the
stimulatory or inhibitory neuronal functions through binding to their respective receptors. In …

Understanding the role of dopamine in cancer: past, present and future

CE Grant, AL Flis, BM Ryan - Carcinogenesis, 2022 - academic.oup.com
Abstract Dopamine (DA, 3-hydroxytyramine) is a member of the catecholamine family and is
classically characterized according to its role in the central nervous system as a …

[HTML][HTML] Chronic stress effects on tumor: pathway and mechanism

H Hong, M Ji, D Lai - Frontiers in oncology, 2021 - frontiersin.org
Chronic stress is an emotional experience that occurs when people encounter something
they cannot adapt to. Repeated chronic stress increases the risk of a variety of diseases …

GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca2+ signalling in a …

SH Jiang, LL Zhu, M Zhang, RK Li, Q Yang, JY Yan… - Gut, 2019 - gut.bmj.com
Background and aims Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of
cancer-related death worldwide. Neurotransmitter-initiated signalling pathway is profoundly …

[HTML][HTML] Role of dopamine receptors in the anticancer activity of ONC201

CLB Kline, MD Ralff, AR Lulla, JM Wagner, PH Abbosh… - Neoplasia, 2018 - Elsevier
ONC201/TIC10 is a first-in-class small molecule inducer of TRAIL that causes early
activation of the integrated stress response. Its promising safety profile and broad-spectrum …

The DRD2 antagonist haloperidol mediates autophagy-induced ferroptosis to increase temozolomide sensitivity by promoting endoplasmic reticulum stress in …

L Shi, H Chen, K Chen, C Zhong, C Song, Y Huang… - Clinical Cancer …, 2023 - AACR
Purpose: Temozolomide resistance remains a major obstacle in the treatment of
glioblastoma (GBM). The combination of temozolomide with another agent could offer an …

[HTML][HTML] LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer

DD Cave, S Buonaiuto, B Sainz Jr, M Fantuz… - Journal of Experimental …, 2022 - Springer
Background Tumor-initiating cells (TIC), also known as cancer stem cells, are considered a
specific subpopulation of cells necessary for cancer initiation and metastasis; however, the …

Cancer and the dopamine D2 receptor: a pharmacological perspective

JS Weissenrieder, JD Neighbors, RB Mailman… - … of Pharmacology and …, 2019 - ASPET
The dopamine D2 receptor (D2R) family is upregulated in many cancers and tied to
stemness. Reduced cancer risk has been correlated with disorders such as schizophrenia …

Biological activity of weekly ONC201 in adult recurrent glioblastoma patients

I Arrillaga-Romany, Y Odia, VV Prabhu… - Neuro …, 2020 - academic.oup.com
Background ONC201 is a dopamine receptor D2 (DRD2) antagonist that penetrates the
blood–brain barrier. ONC201 efficacy has been shown in glioblastoma animal models and …

Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance

G D'Errico, M Alonso-Nocelo, M Vallespinos… - Oncogene, 2019 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is an inherently chemoresistant tumor.
Chemotherapy leads to apoptosis of cancer cells, and in previous studies we have shown …